ISPOR Chief Science Officer Dr Laura Pizzi Named to NJBIZ's 2026 People to Watch in Healthcare List

Published Jul 29, 2026

Lawrenceville, NJ, USA– July 29, 2026—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is proud to announce its Chief Science Officer, Laura Pizzi, PharmD, MPH, has been recognized by NJBIZ as one of its 2026 People to Watch in Healthcare.

The annual NJBIZ recognition honors healthcare leaders across New Jersey who are driving innovation, advancing patient care, and shaping the future of healthcare through their leadership, expertise, and commitment to improving health outcomes.

As Chief Science Officer at ISPOR, Dr Pizzi leads the Society's scientific strategy and initiatives, advancing the role of health economics and outcomes research (HEOR) in informing healthcare decisions globally. Her work helps foster the development and dissemination of scientific evidence that supports policymakers, healthcare providers, payers, life sciences organizations, and patients in making evidence-informed decisions that improve healthcare value and patient outcomes.

"Laura's passion for scientific excellence and her commitment to advancing the field of HEOR have strengthened ISPOR's role as the leading global professional society dedicated to improving healthcare decision making," said Rob Abbott, CEO of ISPOR. This recognition is a testament to her leadership, vision, and the meaningful impact she continues to make across the healthcare community. We are thrilled to celebrate this well-deserved honor."

"I am deeply honored to be recognized by NJBIZ alongside so many inspiring healthcare leaders," said Dr. Pizzi. "This recognition reflects not only my work but also the dedication of my colleagues at ISPOR and the global HEOR community. Together, we are advancing research and evidence that helps improve healthcare decisions and ultimately create better outcomes for patients around the world."

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

Website  | LinkedIn  | X (@ispororg)  |  Bluesky  |  YouTube  |  Facebook  |  Instagram  

Related Stories

New Research and Policy Priorities Chart a Broader Role for HEOR

Oct 15, 2026

Value in Health announced today the publication of a new commentary that calls for expanding the role of health economics and outcomes research (HEOR) and increasing its impact on real-world decision making.

ISPOR Europe 2026 Plenaries Announced

Sep 30, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2026 conference. The conference is the leading global event in Europe for health economics and outcomes research (HEOR) and is scheduled for 8-11 November in Vienna, Austria with the theme, “Shaping the Future of Access Through Science and Policy.”

New Study Sheds Light on QALY and Disability Debate

Sep 28, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a study showing no evidence that the use of quality-adjusted life years (QALYs) inherently disadvantages people with disabilities.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×